The brave new world of genetics and pharmacogenetics research provides some exciting possibilities as well as some major challenges to researchers. Recruiting subjects is top concern.
In January, New Jersey became only the second state in the union to pass legislation formally permitting research using embryonic stem cells.
Exemestane after Tamoxifen Therapy in Breast Cancer; An Analysis of How Long Patients Remain on Various BP Therapies; Endothelial Dysfunction with Insulin Resistance and CWT in Hypertension
A clinical prediction rule helps identify patients with knee pain who might benefit from orthopedic surgery.
Diets low in red meat and fish and high in vegetables and low-fat dairy products are associated with a decrease in the incidence of gout.
Angiotech Pharmaceuticals (Vancouver, British Columbia), a specialty pharmaceutical company focusing on drug-coated medical devices and biomaterials, said it has licensed a portfolio of biomaterial, drug delivery and medical device technologies from Poly-Med (Anderson, South Carolina).
